A Novel Mechanism of EML4-ALK Rearrangement Mediated by Chromothripsis in a Patient-Derived Cell Line-Reference-Cited by-同舟云学术

A Novel Mechanism of EML4-ALK Rearrangement Mediated by Chromothripsis in a Patient-Derived Cell Line

Published:2014-11 Issue:11 Volume:9 Page:1638-1646
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Kodama Tatsushi,Motoi Noriko,Ninomiya Hironori,Sakamoto Hiroshi,Kitada Kunio,Tsukaguchi Toshiyuki,Satoh Yasuko,Nomura Kimie,Nagano Hiroko,Ishii Nobuya,Terui Yasuhito,Hatake Kiyohiko,Ishikawa Yuichi

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference34 articles.

1. Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia;Kantarjian;N Engl J Med,2002

2. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer;Soda;Nature,2007

3. RET, ROS1 and ALK fusions in lung cancer;Takeuchi;Nat Med,2012

4. KIF5B-RET fusions in lung adenocarcinoma;Kohno;Nat Med,2012

5. Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies;Lipson;Nat Med,2012

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A genetic basis for sex differences in Xp11 translocation renal cell carcinoma;Cell;2024-08

2. Scrambling the genome in cancer: causes and consequences of complex chromosome rearrangements;Nature Reviews Genetics;2023-11-08

3. A genetic basis for cancer sex differences revealed in Xp11 translocation renal cell carcinoma;2023-08-06

4. A non-functional 5′ ALK fusion validated at the RNA level as a classical EML4-ALK that responds well to the novel ALK inhibitor ensartinib: A case report;Frontiers in Medicine;2022-10-06

5. EML4‑ALK fusion gene in non‑small cell lung cancer (Review);Oncology Letters;2022-06-24